ÐóññêèéEnglish
Russia: +7 (495) 684-4333

Materia Medica Holding


Is a research and manufacturing company, established in 1993, is the major Russian manufacturer of homeopathic products and original patented drugs based on ultra-low doses of antibodies.

News

25.06.2010

“Men’s Health” 6th All-Russian congress


01.06.2010

"Materia Medica" wishes all children to be healthy and enjoy bright sunny summer!


27.05.2010

State scientific centre for virology and biotechnology “Vector” has confirmed that Anaferon for children is effective against flu virus A (H1N1/09).


News archives

To specialists

Ultralow Doses(History of one Research) Epstein O.I.

A randomized, open-label, comparative, 6-month trial of oral ultra-low doses of antibodies to tumor necrosis factor-α and diclofenac in rheumatoid arthritis. Dudina J.L, Petrov V.I., Babayeva A.R., Martyushev-Poklad A.V., Tcherevkova E.V., Epstein O.I., Sergeeva S.A

Sexual incentive motivation in old male rats: The effects of sildenafil and a compound (Impaza) stimulating endothelial NO synthase. Xi Chu a, Anders Agmo

Read more

Products

Anaferon

Anaferon belongs to the group of immunomodulators and antiviral agents. The drug exerts dual action, that is, early antiviral action mediated through the induction of IFN-α and complementary antiviral ànd full-scale immunomodulatory effects that are realized via IFN-γ production.

All Products

Ñîçäàíèå ñàéòà «Âåá-ñòóäèÿ ITSoft»
OOO NPF Materia Medica Holding
www.materiamedica.ru
9 bld, 3rd Samotyochnyi per., Moscow, 127 473, Russia
+7 (495) 684-4333 E-mail: moffice@materiamedica.ru